iCellVivo
Biotechnology Research • 
Irvine, California, United States • 1-10 Employees
Company overview
| Headquarters | 4100 E Peltason Dr, Irvine, California 92617, US |
| NAICS | 541714 |
| Founded | 2017 |
| Employees | 1-10 |
Key Contact at iCellVivo
John Collins
CEO
About iCellVivo
The cost of drug development has drastically increased to >$1 billion contributing to a decline in the productivity of the pharmaceutical industry. This opens up opportunities for biotech companies like iCellVivo, Inc. to develop next-generation interacting multiple human organ test systems for drug discovery, toxicity testing and 3d stem cell assays potentially reducing the need for animal testing. iCellVivo, Inc. is developing a 6-well based multiorgan platform with integrated electrophysiological assay to improve clinical predictability and reduce animal testing. This patent pending portable, open-well configuration multiorgan platform uses microfluidic plate and 3-D inserts for standard well-plates to perform preclinical toxicity profiling.
iCellVivo revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
iCellVivo has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
iCellVivo has never raised funding before.
Canada
France
Belgium
United Kingdom
EstoniaFrequently asked questions
4.8
40,000 users
